300 Young People Enthusiastically Started Their New Positions at Nobel İlaç

300 Young People Enthusiastically Started Their New Positions at Nobel İlaç
Our General Manager Oğuz Akandil's views on the subject are as follows: "Having 300 new, brilliant colleagues join us is very valuable not only for Nobel İlaç, but also for our industry, our young people and the future of our country. As Nobel İlaç, we will continue to contribute to the health of societies by always keeping our patients in focus!"

In July 2022, the company's organizational structure underwent significant changes and new employment opportunities arose for young people, especially in sales and marketing positions, in line with the company's growth strategy and future vision.
 
Having completed its preparations accordingly, Nobel İlaç included 467 candidates in the New Medical Representative Training, which started on August 31, following an intensive interview and evaluation process. During the intensive six-week training program, candidates received basic medical, promotional and product training.
 
Having successfully completed all the trainings in the best way possible, 300 young people enthusiastically took their place in the company's field staff as Nobel İlaç's new medical representatives on October 10.
 
Oğuz Akandil, General Manager of Nobel İlaç, made the following statement on the subject: "On the eve of the 100th anniversary of our Republic and in the 58th year of our foundation, our greatest effort as Nobel İlaç is to provide accessible and reliable products for human health to every corner of the world. One of the indispensable forces of access to our products in our treatment areas is our medical representatives in the field. In this direction, we decided to grow our existing staff, created new staff, made investments and provided new employment opportunities for our young people. Having 300 new, brilliant colleagues join us is very valuable not only for Nobel İlaç, but also for our industry, our young people and the future of our country. As Nobel İlaç, we will continue to contribute to the health of societies by always keeping our patients in focus!"